ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1816

Five-Year Outcome of Operative and Nonoperative Management of Meniscal Tear in the Presence of Osteoarthritic Changes

Jeffrey N. Katz1, Swastina Shrestha2, Elena Losina3, Lisa A. Mandl4, Bruce Levy5, Kurt Spindler6 and Jamie E. Collins7, 1Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 2Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 3Orthopaedics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Rheumatology, Hospital for Special Surgery, New York, NY, 5Orthopedics, Mayo Clinic, Rochester, MN, 6Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, 7Department of Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: meniscectomy, meniscus, osteoarthritis and physical therapy, Total Knee Arthroplasty (TKA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M042 ACR Abstract: Plenary Session II (1816–1821)

Session Type: ACR Plenary Session

Session Time: 11:00AM-12:30PM

Background/Purpose: While recent trials have examined short-term (~ 2 year) outcomes of surgical and nonoperative treatment of meniscal tear in the setting of osteoarthritis there has been little study of longer term outcomes of these treatments.  

Methods: We examined 5-year outcomes of subjects in MeTeOR (Clintrials.gov NCT00597012), a multicenter randomized trial of physical therapy (PT) vs. PT plus arthroscopic partial meniscectomy (APM) for subjects with knee pain, meniscal tear and OA changes on xray or MRI. The primary outcome for this analysis was the Knee Osteoarthritis and Injury Outcome Score (KOOS) Pain Scale (0-100, 100 worst). Total knee replacement (TKR) was a secondary outcome.  To address changes in KOOS Pain over 5 years, we used a piecewise linear mixed model, stratified by treatment group (randomized to and received APM; randomized to and received PT; randomized to PT but received APM during follow-up). The model censored subjects who had TKR and adjusted for age, sex, BMI, and mental health status. We used a pattern mixture model to assess whether the findings were biased by missing data due to TKR or losses to follow-up.  We calculated the frequency of TKR over follow-up and used a Cox proportional hazards model to estimate the risk of TKR for treatment groups and KL grades, adjusting for baseline factors.

Results: The 351 subjects had mean age 58; 57% were female. 164 were randomized to and received APM; 109 were randomized to and received PT; 68 were randomized to PT and crossed over to receive APM.  10 subjects were randomized to but did not receive APM and were not analyzed. 66% of subjects completed ≥ 9 of 12 follow-up questionnaires, with similar completion rates across treatment groups. The piecewise linear model (Figure) showed similar pain improvement in the 3 treatment groups, with baseline KOOS Pain scores of 40-50 improving to 20-25 by 6 months and little change between 6 and 60 months. The pattern mixture models demonstrated similar patterns in pain scores as the main analysis, suggesting TKR and other losses to follow up did not bias these findings.

25 participants (7%) had TKR over follow-up.  In the Cox model, the hazard of TKR was higher in those treated surgically (randomized to APM or crossed over) than those randomized to and receiving PT (HR 5.0, 95% CI: 1.2, 21.8), and in those with KL-3 radiographs vs. KL0-2 (HR 2.7, 95% CI 1.2, 6.4).

Conclusion: Pain relief was similar across treatment groups, while the few TKR’s were more common in those with KL3 and those receiving APM. These data suggest that persons with degenerative meniscal tear generally experience substantial pain relief over 5 years, irrespective of initial treatment. The greater risk of TKR in those treated with APM could reflect selection effects and/or faster progression of OA following surgery than following PT, and merits further study. 

Fig: KOOS Pain (shaded 95% CI) stratified by treatment in piecewise linear model


Disclosure: J. N. Katz, None; S. Shrestha, None; E. Losina, Samumed, 5,JBJS, 5; L. A. Mandl, None; B. Levy, Arthrex, 2, 5, 7,Smith and Nephew, 2, 5; K. Spindler, None; J. E. Collins, None.

To cite this abstract in AMA style:

Katz JN, Shrestha S, Losina E, Mandl LA, Levy B, Spindler K, Collins JE. Five-Year Outcome of Operative and Nonoperative Management of Meniscal Tear in the Presence of Osteoarthritic Changes [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/five-year-outcome-of-operative-and-nonoperative-management-of-meniscal-tear-in-the-presence-of-osteoarthritic-changes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/five-year-outcome-of-operative-and-nonoperative-management-of-meniscal-tear-in-the-presence-of-osteoarthritic-changes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology